Breaking News, Collaborations & Alliances

Boehringer Ingelheim and Inventiva Collaborate

Will develop potential new treatments for idiopathic pulmonary fibrosis

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim and Inventiva, a French biopharmaceutical company specialized in the development of therapies for fibrosis, oncology and orphan diseases, have formed a new multi-year research and drug discovery collaboration and licensing agreement. The Inventiva and Boehringer Ingelheim research teams will jointly validate a new therapeutic concept with the aim of discovering new medicines for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. The partners...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters